Kelso A, Owens T
Cancer Research Unit, Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.
J Immunol. 1988 Feb 15;140(4):1159-67.
A method has been developed to measure the production by single activated T lymphocytes of two hemopoietic growth factors, granulocyte-macrophage CSF (GM-CSF) and multipotential CSF (multi-CSF or IL-3). When individual cells of the L3T4 (CD4)+ F23.1+ T cell clone E9.D4 were transferred by micromanipulation into wells coated with the monoclonal anti-T cell receptor antibody F23.1, up to 90% of cells produced CSF as detected by CSF-dependent hemopoietic cell lines. Production occurred in the absence of proliferation and did not require the addition of accessory cells or IL-2. Both the frequency of CSF-producing cells and the average production per positive cell depended on the density of the immobilized stimulating ligand, indicating that the response of each cell is not an all-or-none phenomenon but varies with the strength of stimulation. Individual cells of the clone varied over a 100-fold range in their total CSF titer with a mean value of about 0.05 U/cell. They also varied in their relative production of GM-CSF and multi-CSF. Thus, low producing cells secreted only GM-CSF whereas high producing cells also secreted multi-CSF. The failure of low producing cells to secrete multi-CSF was not genetically based since such cells could give rise to progeny that synthesized multi-CSF. These results suggest that the synthesis of these two lymphokines can be differentially regulated at the level of the single cell.
已开发出一种方法来测量单个活化T淋巴细胞产生的两种造血生长因子,即粒细胞-巨噬细胞集落刺激因子(GM-CSF)和多能集落刺激因子(多-CSF或IL-3)。当通过显微操作将L3T4(CD4)+ F23.1 + T细胞克隆E9.D4的单个细胞转移到包被有单克隆抗T细胞受体抗体F23.1的孔中时,高达90%的细胞产生了集落刺激因子,这可通过依赖集落刺激因子的造血细胞系检测到。集落刺激因子的产生在没有细胞增殖的情况下发生,并且不需要添加辅助细胞或IL-2。产生集落刺激因子的细胞频率和每个阳性细胞的平均产量均取决于固定化刺激配体的密度,这表明每个细胞的反应不是全或无现象,而是随刺激强度而变化。该克隆的单个细胞的总集落刺激因子滴度在100倍的范围内变化,平均值约为0.05 U/细胞。它们在GM-CSF和多-CSF的相对产量上也有所不同。因此,低产细胞仅分泌GM-CSF,而高产细胞还分泌多-CSF。低产细胞不能分泌多-CSF并非基于遗传,因为此类细胞可以产生合成多-CSF的后代。这些结果表明,这两种淋巴因子的合成可以在单细胞水平上受到差异调节。